In recent months, Vor Biopharma closed a US$424.83 million shelf registration, repriced employee stock options, and reported positive late-stage clinical data for its autoimmune drug candidate ...
BOSTON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it has entered into a ...
Learn how open APIs give durable medical equipment (DME) providers the control and flexibility to future-proof their tech stack. Legacy systems were built ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses at a clutch of other firms. Cambridge, ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Investing.com - TD Cowen initiated coverage on Vor Biopharma, Inc. (NASDAQ:VOR) with a Buy rating on Wednesday, citing the potential of the company’s telitacicept therapy. The stock, currently trading ...
Abstract: Positioning with a help of navigational aids data are considered as main backup method is used in civil aviation. Currently, the ground network of navigational aids is minimized to guarantee ...
Vor Bio (NASDAQ: VOR) announced on Monday that it has entered into a securities purchase agreement to sell 13.87M shares of its common stock at a price of $10.81 per share in a private placement. The ...
It is our mission to be the go to leaders in the aviation industry. GlobalAir.com is your partner in connecting you with relevant information and resources.
It is our mission to be the go to leaders in the aviation industry. GlobalAir.com is your partner in connecting you with relevant information and resources.